Can Aydogdu

5PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersComputational physiologyRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 02, 2026
Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer.

|Apr 02, 2026
Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approach.

Jayant Siva, Can Aydogdu, Nicholas Heller

|Mar 28, 2026
Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC).

Michael Staehler, Iulia Blajan, Can Aydogdu

|Jun 27, 2024
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology Center.

Severin Rodler, Can Aydogdu, Isabel Brinkmann

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

Pageof 1

Frequent Collaborators

2 joint publications

Gerald B Schulz

1 joint publications

Niklas Klümper

1 joint publications

Ngoc Khanh Tran

1 joint publications

Oliver Hahn